1,723 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

Janssen Acquisitions

Janssen has acquired 5 companies and its latest acquisition was Anakuria Therapeutics, Inc on Feb 2022

Unlock 2 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

Anakuria Therapeutics, Inc

Feb 2022

Source »
undisclosed
-
Benevir Biopharm, Inc.

May 2018

Source »
$140M
BeneVir is a biotechnology company that focuses on developing oncolytic immunotherapies for the treatment of cancer.
Xo1 Ltd

Mar 2015

Source »
undisclosed
XO1 is a virtual biopharmaceutical firm that develops ichorcumab an anti-thrombin antibody that delivers anticoagulation without bleeding.
Ceptaris Therapeutics, Inc.

Jul 2013

Source »
$250M
Ceptaris Therapeutics, is a specialty pharmaceutical company and develops mechlorethamine gels.

-

Axovan AG

Sep 2003

Source »
$45.2M
-

Frequently Asked Questions about Janssen

  1. What companies did Janssen acquire?

    Companies acquired by Janssen include , Benevir and Xo1

  2. How many acquisitions does Janssen have?

    Janssen has acquired 5 companies including , Benevir and Xo1.

  1. How many acquisitions did Janssen make in 2022?

    In 2022 Janssen acquired 1 companies including undefined.